Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 3, 2022

Total Value ($000): $399,584 (100.0% shares, 0.0% debt)

Holdings (7)

CNTA CENTESSA PHARMACEUTICALS PLC 51.1%

Value ($000) $204,075 Shares 18,123,892 Est. Cost $22.09 Unrealized —

AURA AURA BIOSCIENCES INC 12.9%

Value ($000) $51,617 Shares 3,039,892 Est. Cost $17.87 Unrealized 0.0%

— MERUS N V 12.7%

Value ($000) $50,880 Shares 1,600,000 Est. Cost $14.08 Unrealized —

PCVX VAXCYTE INC 11.2%

Value ($000) $44,903 Shares 1,887,478 Est. Cost $32.16 Unrealized -27.7%

PHAT PHATHOM PHARMACEUTICALS INC 10.2%

Value ($000) $40,675 Shares 2,067,861 Est. Cost $25.13 Unrealized -6.4%

— CHECKMATE PHARMACEUTICALS IN 1.1%

Value ($000) $4,310 Shares 1,501,716 Est. Cost $11.51 Unrealized —

— OBSEVA SA 0.8%

Value ($000) $3,124 Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	18,123,892	$204,075	51.1%	$22.09	—	SPONSORED ADS	152309100
AURA	AURA BIOSCIENCES INC	3,039,892	$51,617	12.9%	$17.87	0.0%	COM	05153U107
—	MERUS N V	1,600,000	$50,880	12.7%	$14.08	—	COM	N5749R100
PCVX	VAXCYTE INC	1,887,478	$44,903	11.2%	$32.16	-27.7%	COM	92243G108
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$40,675	10.2%	$25.13	-6.4%	COM	71722W107
—	CHECKMATE PHARMACEUTICALS IN	1,501,716	$4,310	1.1%	$11.51	—	COM	162818108
—	OBSEVA SA	1,570,000	$3,124	0.8%	$3.82	—	COM	H5861P103